The functionalvanGCdcluster ofClostridium difficiledoes not confer vancomycin resistance

Staphylococcus aureus VRSA-11B Is a Constitutive Vancomycin-Resistant Mutant of Vancomycin-Dependent VRSA-11A

(2012) Bruno Périchon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Distribution of the vanG-like gene cluster in Clostridium difficile clinical isolates

(2012) Fariza Ammam et al.   CANADIAN JOURNAL OF MICROBIOLOGY

The rise of the Enterococcus: beyond vancomycin resistance

(2012) Cesar A. Arias et al.   NATURE REVIEWS MICROBIOLOGY

d-Ala-d-Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium

(2011) François Lebreton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clostridium difficileHas an Original Peptidoglycan Structure with a High Level ofN-Acetylglucosamine Deacetylation and Mainly 3-3 Cross-links

(2011) Johann Peltier et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Reannotation of the genome sequence of Clostridium difficile strain 630

(2011) M. Monot et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Acquisition of VanB-type vancomycin resistance by Bacillus subtilis: the impact on gene expression, cell wall composition and morphology

(2011) Paola Bisicchia et al.   MOLECULAR MICROBIOLOGY

Treatment of refractory and recurrent Clostridium difficile infection

(2011) Christina M. Surawicz et al.   Nature Reviews Gastroenterology & Hepatology

vanM, a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium

(2010) X. Xu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

CcpA-mediated repression of Clostridium difficile toxin gene expression

(2010) Ana Antunes et al.   MOLECULAR MICROBIOLOGY

A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor

(2010) Kalinka Koteva et al.   Nature Chemical Biology

Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci

(2010) M.-L. Foucault et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Crystallization and preliminary X-ray analysis of aD-Ala:D-Ser ligase associated with VanG-type vancomycin resistance

(2009) Patrick Weber et al.   Acta Crystallographica Section F-Structural Biology and Crystallization Communications

New Combinations of Mutations in VanD-Type Vancomycin-Resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium Strains

(2009) F. Depardieu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

DD-Ligases as a Potential Target for Antibiotics: Past, Present and Future

(2009) I. Tytgat et al.   CURRENT MEDICINAL CHEMISTRY

A modular system for Clostridium shuttle plasmids

(2009) John T. Heap et al.   JOURNAL OF MICROBIOLOGICAL METHODS

The ClosTron: Mutagenesis in Clostridium refined and streamlined

(2009) John T. Heap et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp.

(2008) L. Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Characterization of Enterococcus faecalis N06-0364 with Low-Level Vancomycin Resistance Harboring a Novel D-Ala-D-Ser Gene Cluster, vanL

(2008) D. A. Boyd et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Substrate specificity of bacterial DD-peptidases (penicillin-binding proteins)

(2008) R. F. Pratt   CELLULAR AND MOLECULAR LIFE SCIENCES

Actualités sur les infections à Clostridium difficile

(2007) K. Blanckaert et al.   REVUE DE MEDECINE INTERNE